Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsDuncan McKechnie has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Vertex Pharmaceuticals Inc on October 24, 2026. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
“Firstly, about 70% of the IGAM patients are commercial patients, so our focus really is the commercial business, the three PBMs there. We have been working with them and engaging with them since July 2025.”
“I'll start with CF, which continues to perform very well. Year-over-year revenue growth was 6% globally, balanced nicely between U.S. growth of 5% and international growth of 8% in quarter one.”
Source not stated
Biotechnology · Healthcare
